Skip to main content
Premium Trial:

Request an Annual Quote

Analysis Finds Limits in Standardization of Genetic, Genomic Lab Reports

A new analysis underscores the limited standardization of genetic and genomic laboratory testing reports in the US. In the Journal of Molecular Diagnostics, a University of Utah and ARUP Laboratories-led team examined 95 test reports describing 113 assay results from 56 patients within the Connect Myeloid Disease Registry. In their pilot study, which was supported by Celgene, the team found that 89 percent of the assay results described the sequencing technology used and 84 percent described the limits of detection. However, the researchers note many labs did not fully describe those limits or their methods. The team further found that 18 reports from one CAP/CLIA certified lab did not give RNA transcript identifiers and that some labs, even ones that gave transcript identifiers, used nonstandard names. This, the researchers say, say could make it difficult to definitively identify the variant and could affect patient care. "This pilot study demonstrated that limitations in the accuracy, transparency, and consistency of genetic and genomic laboratory reports make the standardization, collation, analysis, and interpretation of high-quality data across laboratories and providers impossible," the researchers write.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.